Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Hemostatic Forceps Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Hemostatic Forceps Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-09-11
Pages: 200 Pages
Report ld: 5038615
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Hemostatic Forceps Market Size(US$)
CAGR 2025-2031
4.3%
Market Size,2031
USD 87.2
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 67.8 million
Market Forecast in 2031(Value)
US$ 87.2 million
CAGR
4.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Hemostatic Forceps market is projected to grow from US$ 65.2 million in 2024 to US$ 87.2 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
For different application, there are generally three types of hemostatic forceps, which include Halstead mosquito hemostatic forceps, Kelly and Crile hemostatic forceps and Rochester-Carmalt hemostatic forceps.
Global Hemostatic Forceps key players include Medline, B. Braun, CareFusion, Sklar, Scanlan International, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 30%, followed by Europe and China, both have a share about 45%.
In terms of product, Halstead Mosquito Hemostatic Forceps is the largest segment, with a share over 55%.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Hemostatic Forceps market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Medline
- B. Braun
- CareFusion
- Asa Dental
- Sklar
- Scanlan International
- Shanghai Medical Instruments
- Lawton
- Hu-Friedy
- Xinhua Surgical
- Towne Brothers
- Teleflex Medical
- Delacroix Chevalier
- YDM
- M A Corporation
- MedGyn Products
- Inami
- Ted Pella
- Medicon eG
- J & J Instruments
- American Diagnostic
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Halstead Mosquito Hemostatic Forceps
- Kelly and Crile Hemostatic Forceps
- Rochester-Carmalt Hemostatic Forceps
Segment by Application
- Surgical
- Dissection
- Dental
- Laparoscopic
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Hemostatic Forceps study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Hemostatic Forceps: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Hemostatic Forceps Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Halstead Mosquito Hemostatic Forceps
1.2.3 Kelly and Crile Hemostatic Forceps
1.2.4 Rochester-Carmalt Hemostatic Forceps
1.3 Market Segmentation by Application
1.3.1 Global Hemostatic Forceps Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Surgical
1.3.3 Dissection
1.3.4 Dental
1.3.5 Laparoscopic
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Hemostatic Forceps Revenue Estimates and Forecasts 2020-2031
2.2 Global Hemostatic Forceps Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Hemostatic Forceps Sales Estimates and Forecasts 2020-2031
2.4 Global Hemostatic Forceps Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Hemostatic Forceps Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Hemostatic Forceps Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Halstead Mosquito Hemostatic Forceps Market Size by Manufacturers
3.5.2 Kelly and Crile Hemostatic Forceps Market Size by Manufacturers
3.5.3 Rochester-Carmalt Hemostatic Forceps Market Size by Manufacturers
3.6 Global Hemostatic Forceps Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Hemostatic Forceps Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Hemostatic Forceps Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Hemostatic Forceps Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Hemostatic Forceps Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Hemostatic Forceps Sales and Revenue by Type (2020-2031)
6.4 North America Hemostatic Forceps Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Hemostatic Forceps Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Hemostatic Forceps Sales and Revenue by Type (2020-2031)
7.4 Europe Hemostatic Forceps Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Hemostatic Forceps Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Hemostatic Forceps Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Hemostatic Forceps Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Hemostatic Forceps Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Hemostatic Forceps Sales and Revenue by Type (2020-2031)
9.4 Central and South America Hemostatic Forceps Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Hemostatic Forceps Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Hemostatic Forceps Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Hemostatic Forceps Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Hemostatic Forceps Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medline
11.1.1 Medline Corporation Information
11.1.2 Medline Business Overview
11.1.3 Medline Hemostatic Forceps Product Models, Descriptions and Specifications
11.1.4 Medline Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Medline Hemostatic Forceps Sales by Product in 2024
11.1.6 Medline Hemostatic Forceps Sales by Application in 2024
11.1.7 Medline Hemostatic Forceps Sales by Geographic Area in 2024
11.1.8 Medline Hemostatic Forceps SWOT Analysis
11.1.9 Medline Recent Developments
11.2 B. Braun
11.2.1 B. Braun Corporation Information
11.2.2 B. Braun Business Overview
11.2.3 B. Braun Hemostatic Forceps Product Models, Descriptions and Specifications
11.2.4 B. Braun Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 B. Braun Hemostatic Forceps Sales by Product in 2024
11.2.6 B. Braun Hemostatic Forceps Sales by Application in 2024
11.2.7 B. Braun Hemostatic Forceps Sales by Geographic Area in 2024
11.2.8 B. Braun Hemostatic Forceps SWOT Analysis
11.2.9 B. Braun Recent Developments
11.3 CareFusion
11.3.1 CareFusion Corporation Information
11.3.2 CareFusion Business Overview
11.3.3 CareFusion Hemostatic Forceps Product Models, Descriptions and Specifications
11.3.4 CareFusion Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 CareFusion Hemostatic Forceps Sales by Product in 2024
11.3.6 CareFusion Hemostatic Forceps Sales by Application in 2024
11.3.7 CareFusion Hemostatic Forceps Sales by Geographic Area in 2024
11.3.8 CareFusion Hemostatic Forceps SWOT Analysis
11.3.9 CareFusion Recent Developments
11.4 Asa Dental
11.4.1 Asa Dental Corporation Information
11.4.2 Asa Dental Business Overview
11.4.3 Asa Dental Hemostatic Forceps Product Models, Descriptions and Specifications
11.4.4 Asa Dental Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Asa Dental Hemostatic Forceps Sales by Product in 2024
11.4.6 Asa Dental Hemostatic Forceps Sales by Application in 2024
11.4.7 Asa Dental Hemostatic Forceps Sales by Geographic Area in 2024
11.4.8 Asa Dental Hemostatic Forceps SWOT Analysis
11.4.9 Asa Dental Recent Developments
11.5 Sklar
11.5.1 Sklar Corporation Information
11.5.2 Sklar Business Overview
11.5.3 Sklar Hemostatic Forceps Product Models, Descriptions and Specifications
11.5.4 Sklar Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Sklar Hemostatic Forceps Sales by Product in 2024
11.5.6 Sklar Hemostatic Forceps Sales by Application in 2024
11.5.7 Sklar Hemostatic Forceps Sales by Geographic Area in 2024
11.5.8 Sklar Hemostatic Forceps SWOT Analysis
11.5.9 Sklar Recent Developments
11.6 Scanlan International
11.6.1 Scanlan International Corporation Information
11.6.2 Scanlan International Business Overview
11.6.3 Scanlan International Hemostatic Forceps Product Models, Descriptions and Specifications
11.6.4 Scanlan International Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Scanlan International Recent Developments
11.7 Shanghai Medical Instruments
11.7.1 Shanghai Medical Instruments Corporation Information
11.7.2 Shanghai Medical Instruments Business Overview
11.7.3 Shanghai Medical Instruments Hemostatic Forceps Product Models, Descriptions and Specifications
11.7.4 Shanghai Medical Instruments Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Shanghai Medical Instruments Recent Developments
11.8 Lawton
11.8.1 Lawton Corporation Information
11.8.2 Lawton Business Overview
11.8.3 Lawton Hemostatic Forceps Product Models, Descriptions and Specifications
11.8.4 Lawton Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Lawton Recent Developments
11.9 Hu-Friedy
11.9.1 Hu-Friedy Corporation Information
11.9.2 Hu-Friedy Business Overview
11.9.3 Hu-Friedy Hemostatic Forceps Product Models, Descriptions and Specifications
11.9.4 Hu-Friedy Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Hu-Friedy Recent Developments
11.10 Xinhua Surgical
11.10.1 Xinhua Surgical Corporation Information
11.10.2 Xinhua Surgical Business Overview
11.10.3 Xinhua Surgical Hemostatic Forceps Product Models, Descriptions and Specifications
11.10.4 Xinhua Surgical Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Xinhua Surgical Recent Developments
11.11 Towne Brothers
11.11.1 Towne Brothers Corporation Information
11.11.2 Towne Brothers Business Overview
11.11.3 Towne Brothers Hemostatic Forceps Product Models, Descriptions and Specifications
11.11.4 Towne Brothers Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Towne Brothers Recent Developments
11.12 Teleflex Medical
11.12.1 Teleflex Medical Corporation Information
11.12.2 Teleflex Medical Business Overview
11.12.3 Teleflex Medical Hemostatic Forceps Product Models, Descriptions and Specifications
11.12.4 Teleflex Medical Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Teleflex Medical Recent Developments
11.13 Delacroix Chevalier
11.13.1 Delacroix Chevalier Corporation Information
11.13.2 Delacroix Chevalier Business Overview
11.13.3 Delacroix Chevalier Hemostatic Forceps Product Models, Descriptions and Specifications
11.13.4 Delacroix Chevalier Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Delacroix Chevalier Recent Developments
11.14 YDM
11.14.1 YDM Corporation Information
11.14.2 YDM Business Overview
11.14.3 YDM Hemostatic Forceps Product Models, Descriptions and Specifications
11.14.4 YDM Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 YDM Recent Developments
11.15 M A Corporation
11.15.1 M A Corporation Corporation Information
11.15.2 M A Corporation Business Overview
11.15.3 M A Corporation Hemostatic Forceps Product Models, Descriptions and Specifications
11.15.4 M A Corporation Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 M A Corporation Recent Developments
11.16 MedGyn Products
11.16.1 MedGyn Products Corporation Information
11.16.2 MedGyn Products Business Overview
11.16.3 MedGyn Products Hemostatic Forceps Product Models, Descriptions and Specifications
11.16.4 MedGyn Products Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 MedGyn Products Recent Developments
11.17 Inami
11.17.1 Inami Corporation Information
11.17.2 Inami Business Overview
11.17.3 Inami Hemostatic Forceps Product Models, Descriptions and Specifications
11.17.4 Inami Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Inami Recent Developments
11.18 Ted Pella
11.18.1 Ted Pella Corporation Information
11.18.2 Ted Pella Business Overview
11.18.3 Ted Pella Hemostatic Forceps Product Models, Descriptions and Specifications
11.18.4 Ted Pella Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Ted Pella Recent Developments
11.19 Medicon eG
11.19.1 Medicon eG Corporation Information
11.19.2 Medicon eG Business Overview
11.19.3 Medicon eG Hemostatic Forceps Product Models, Descriptions and Specifications
11.19.4 Medicon eG Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Medicon eG Recent Developments
11.20 J & J Instruments
11.20.1 J & J Instruments Corporation Information
11.20.2 J & J Instruments Business Overview
11.20.3 J & J Instruments Hemostatic Forceps Product Models, Descriptions and Specifications
11.20.4 J & J Instruments Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 J & J Instruments Recent Developments
11.21 American Diagnostic
11.21.1 American Diagnostic Corporation Information
11.21.2 American Diagnostic Business Overview
11.21.3 American Diagnostic Hemostatic Forceps Product Models, Descriptions and Specifications
11.21.4 American Diagnostic Hemostatic Forceps Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 American Diagnostic Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Hemostatic Forceps Industry Chain
12.2 Hemostatic Forceps Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Hemostatic Forceps Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Hemostatic Forceps Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Hemostatic Forceps Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Hemostatic Forceps Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Hemostatic Forceps Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Hemostatic Forceps Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Hemostatic Forceps Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Hemostatic Forceps Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Hemostatic Forceps Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Hemostatic Forceps Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Hemostatic Forceps Sales by Region (2020-2025) & (K Units)
Table 8. Global Hemostatic Forceps Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Hemostatic Forceps Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Hemostatic Forceps Sales Share by Manufacturers (2020-2025)
Table 12. Global Hemostatic Forceps Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Hemostatic Forceps Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Hemostatic Forceps by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostatic Forceps as of 2024)
Table 16. Global Hemostatic Forceps Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Hemostatic Forceps Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/Unit)
Table 18. Key Manufacturers Hemostatic Forceps Manufacturing Base and Headquarters
Table 19. Global Hemostatic Forceps Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Hemostatic Forceps Sales by Type (2020-2025) & (K Units)
Table 23. Global Hemostatic Forceps Sales by Type (2026-2031) & (K Units)
Table 24. Global Hemostatic Forceps Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Hemostatic Forceps Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Hemostatic Forceps ASP by Type (2020-2031) & (USD/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Hemostatic Forceps Sales by Application (2020-2025) & (K Units)
Table 29. Global Hemostatic Forceps Sales by Application (2026-2031) & (K Units)
Table 30. Hemostatic Forceps High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Hemostatic Forceps Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Hemostatic Forceps Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Hemostatic Forceps ASP by Application (2020-2031) & (USD/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Hemostatic Forceps Growth Accelerators and Market Barriers
Table 37. North America Hemostatic Forceps Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Hemostatic Forceps Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Hemostatic Forceps Growth Accelerators and Market Barriers
Table 40. Europe Hemostatic Forceps Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Hemostatic Forceps Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Hemostatic Forceps Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Hemostatic Forceps Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Hemostatic Forceps Growth Accelerators and Market Barriers
Table 45. Southeast Asia Hemostatic Forceps Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Hemostatic Forceps Investment Opportunities and Key Challenges
Table 47. Central and South America Hemostatic Forceps Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Hemostatic Forceps Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Hemostatic Forceps Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Medline Corporation Information
Table 51. Medline Description and Major Businesses
Table 52. Medline Product Models, Descriptions and Specifications
Table 53. Medline Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 54. Medline Sales Value Proportion by Product in 2024
Table 55. Medline Sales Value Proportion by Application in 2024
Table 56. Medline Sales Value Proportion by Geographic Area in 2024
Table 57. Medline Hemostatic Forceps SWOT Analysis
Table 58. Medline Recent Developments
Table 59. B. Braun Corporation Information
Table 60. B. Braun Description and Major Businesses
Table 61. B. Braun Product Models, Descriptions and Specifications
Table 62. B. Braun Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. B. Braun Sales Value Proportion by Product in 2024
Table 64. B. Braun Sales Value Proportion by Application in 2024
Table 65. B. Braun Sales Value Proportion by Geographic Area in 2024
Table 66. B. Braun Hemostatic Forceps SWOT Analysis
Table 67. B. Braun Recent Developments
Table 68. CareFusion Corporation Information
Table 69. CareFusion Description and Major Businesses
Table 70. CareFusion Product Models, Descriptions and Specifications
Table 71. CareFusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. CareFusion Sales Value Proportion by Product in 2024
Table 73. CareFusion Sales Value Proportion by Application in 2024
Table 74. CareFusion Sales Value Proportion by Geographic Area in 2024
Table 75. CareFusion Hemostatic Forceps SWOT Analysis
Table 76. CareFusion Recent Developments
Table 77. Asa Dental Corporation Information
Table 78. Asa Dental Description and Major Businesses
Table 79. Asa Dental Product Models, Descriptions and Specifications
Table 80. Asa Dental Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Asa Dental Sales Value Proportion by Product in 2024
Table 82. Asa Dental Sales Value Proportion by Application in 2024
Table 83. Asa Dental Sales Value Proportion by Geographic Area in 2024
Table 84. Asa Dental Hemostatic Forceps SWOT Analysis
Table 85. Asa Dental Recent Developments
Table 86. Sklar Corporation Information
Table 87. Sklar Description and Major Businesses
Table 88. Sklar Product Models, Descriptions and Specifications
Table 89. Sklar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Sklar Sales Value Proportion by Product in 2024
Table 91. Sklar Sales Value Proportion by Application in 2024
Table 92. Sklar Sales Value Proportion by Geographic Area in 2024
Table 93. Sklar Hemostatic Forceps SWOT Analysis
Table 94. Sklar Recent Developments
Table 95. Scanlan International Corporation Information
Table 96. Scanlan International Description and Major Businesses
Table 97. Scanlan International Product Models, Descriptions and Specifications
Table 98. Scanlan International Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 99. Scanlan International Recent Developments
Table 100. Shanghai Medical Instruments Corporation Information
Table 101. Shanghai Medical Instruments Description and Major Businesses
Table 102. Shanghai Medical Instruments Product Models, Descriptions and Specifications
Table 103. Shanghai Medical Instruments Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Shanghai Medical Instruments Recent Developments
Table 105. Lawton Corporation Information
Table 106. Lawton Description and Major Businesses
Table 107. Lawton Product Models, Descriptions and Specifications
Table 108. Lawton Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 109. Lawton Recent Developments
Table 110. Hu-Friedy Corporation Information
Table 111. Hu-Friedy Description and Major Businesses
Table 112. Hu-Friedy Product Models, Descriptions and Specifications
Table 113. Hu-Friedy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. Hu-Friedy Recent Developments
Table 115. Xinhua Surgical Corporation Information
Table 116. Xinhua Surgical Description and Major Businesses
Table 117. Xinhua Surgical Product Models, Descriptions and Specifications
Table 118. Xinhua Surgical Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 119. Xinhua Surgical Recent Developments
Table 120. Towne Brothers Corporation Information
Table 121. Towne Brothers Description and Major Businesses
Table 122. Towne Brothers Product Models, Descriptions and Specifications
Table 123. Towne Brothers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 124. Towne Brothers Recent Developments
Table 125. Teleflex Medical Corporation Information
Table 126. Teleflex Medical Description and Major Businesses
Table 127. Teleflex Medical Product Models, Descriptions and Specifications
Table 128. Teleflex Medical Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 129. Teleflex Medical Recent Developments
Table 130. Delacroix Chevalier Corporation Information
Table 131. Delacroix Chevalier Description and Major Businesses
Table 132. Delacroix Chevalier Product Models, Descriptions and Specifications
Table 133. Delacroix Chevalier Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 134. Delacroix Chevalier Recent Developments
Table 135. YDM Corporation Information
Table 136. YDM Description and Major Businesses
Table 137. YDM Product Models, Descriptions and Specifications
Table 138. YDM Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 139. YDM Recent Developments
Table 140. M A Corporation Corporation Information
Table 141. M A Corporation Description and Major Businesses
Table 142. M A Corporation Product Models, Descriptions and Specifications
Table 143. M A Corporation Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 144. M A Corporation Recent Developments
Table 145. MedGyn Products Corporation Information
Table 146. MedGyn Products Description and Major Businesses
Table 147. MedGyn Products Product Models, Descriptions and Specifications
Table 148. MedGyn Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 149. MedGyn Products Recent Developments
Table 150. Inami Corporation Information
Table 151. Inami Description and Major Businesses
Table 152. Inami Product Models, Descriptions and Specifications
Table 153. Inami Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 154. Inami Recent Developments
Table 155. Ted Pella Corporation Information
Table 156. Ted Pella Description and Major Businesses
Table 157. Ted Pella Product Models, Descriptions and Specifications
Table 158. Ted Pella Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 159. Ted Pella Recent Developments
Table 160. Medicon eG Corporation Information
Table 161. Medicon eG Description and Major Businesses
Table 162. Medicon eG Product Models, Descriptions and Specifications
Table 163. Medicon eG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 164. Medicon eG Recent Developments
Table 165. J & J Instruments Corporation Information
Table 166. J & J Instruments Description and Major Businesses
Table 167. J & J Instruments Product Models, Descriptions and Specifications
Table 168. J & J Instruments Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 169. J & J Instruments Recent Developments
Table 170. American Diagnostic Corporation Information
Table 171. American Diagnostic Description and Major Businesses
Table 172. American Diagnostic Product Models, Descriptions and Specifications
Table 173. American Diagnostic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 174. American Diagnostic Recent Developments
Table 175. Key Raw Materials Distribution
Table 176. Raw Materials Key Suppliers
Table 177. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 178. Milestones in Production Technology Evolution
Table 179. Distributors List
Table 180. Market Trends and Market Evolution
Table 181. Market Drivers and Opportunities
Table 182. Market Challenges, Risks, and Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemostatic Forceps Product Picture
Figure 2. Global Hemostatic Forceps Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Halstead Mosquito Hemostatic Forceps Product Picture
Figure 4. Kelly and Crile Hemostatic Forceps Product Picture
Figure 5. Rochester-Carmalt Hemostatic Forceps Product Picture
Figure 6. Global Hemostatic Forceps Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Surgical
Figure 8. Dissection
Figure 9. Dental
Figure 10. Laparoscopic
Figure 11. Others
Figure 12. Hemostatic Forceps Report Years Considered
Figure 13. Global Hemostatic Forceps Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Hemostatic Forceps Revenue (2020-2031) & (US$ Million)
Figure 15. Global Hemostatic Forceps Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Hemostatic Forceps Revenue Market Share by Region (2020-2031)
Figure 17. Global Hemostatic Forceps Sales (2020-2031) & (K Units)
Figure 18. Global Hemostatic Forceps Sales (CAGR) by Region (2020-2031) (K Units)
Figure 19. Global Hemostatic Forceps Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers Hemostatic Forceps Sales Volume Market Share in 2024
Figure 21. Global Hemostatic Forceps Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. Halstead Mosquito Hemostatic Forceps Revenue Market Share by Manufacturer in 2024
Figure 24. Kelly and Crile Hemostatic Forceps Revenue Market Share by Manufacturer in 2024
Figure 25. Rochester-Carmalt Hemostatic Forceps Revenue Market Share by Manufacturer in 2024
Figure 26. Global Hemostatic Forceps Sales Market Share by Type (2020-2031)
Figure 27. Global Hemostatic Forceps Revenue Market Share by Type (2020-2031)
Figure 28. Global Hemostatic Forceps Sales Market Share by Application (2020-2031)
Figure 29. Global Hemostatic Forceps Revenue Market Share by Application (2020-2031)
Figure 30. North America Hemostatic Forceps Sales YoY (2020-2031) & (K Units)
Figure 31. North America Hemostatic Forceps Revenue YoY (2020-2031) & (US$ Million)
Figure 32. North America Top 5 Manufacturers Hemostatic Forceps Sales Revenue (US$ Million) in 2024
Figure 33. North America Hemostatic Forceps Sales Volume (K Units) by Type (2020- 2031)
Figure 34. North America Hemostatic Forceps Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 35. North America Hemostatic Forceps Sales Volume (K Units) by Application (2020-2031)
Figure 36. North America Hemostatic Forceps Sales Revenue (US$ Million) by Application (2020-2031)
Figure 37. US Hemostatic Forceps Revenue (2020-2031) & (US$ Million)
Figure 38. Canada Hemostatic Forceps Revenue (2020-2031) & (US$ Million)
Figure 39. Mexico Hemostatic Forceps Revenue (2020-2031) & (US$ Million)
Figure 40. Europe Hemostatic Forceps Sales YoY (2020-2031) & (K Units)
Figure 41. Europe Hemostatic Forceps Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Europe Top 5 Manufacturers Hemostatic Forceps Sales Revenue (US$ Million) in 2024
Figure 43. Europe Hemostatic Forceps Sales Volume (K Units) by Type (2020-2031)
Figure 44. Europe Hemostatic Forceps Sales Revenue (US$ Million) by Type (2020-2031)
Figure 45. Europe Hemostatic Forceps Sales Volume (K Units) by Application (2020-2031)
Figure 46. Europe Hemostatic Forceps Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. Germany Hemostatic Forceps Revenue (2020-2031) & (US$ Million)
Figure 48. France Hemostatic Forceps Revenue (2020-2031) & (US$ Million)
Figure 49. U.K. Hemostatic Forceps Revenue (2020-2031) & (US$ Million)
Figure 50. Italy Hemostatic Forceps Revenue (2020-2031) & (US$ Million)
Figure 51. Russia Hemostatic Forceps Revenue (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Hemostatic Forceps Sales YoY (2020-2031) & (K Units)
Figure 53. Asia-Pacific Hemostatic Forceps Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Top 8 Manufacturers Hemostatic Forceps Sales Revenue (US$ Million) in 2024
Figure 55. Asia-Pacific Hemostatic Forceps Sales Volume (K Units) by Type (2020- 2031)
Figure 56. Asia-Pacific Hemostatic Forceps Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 57. Asia-Pacific Hemostatic Forceps Sales Volume (K Units) by Application (2020-2031)
Figure 58. Asia-Pacific Hemostatic Forceps Sales Revenue (US$ Million) by Application (2020-2031)
Figure 59. Indonesia Hemostatic Forceps Revenue (2020-2031) & (US$ Million)
Figure 60. Japan Hemostatic Forceps Revenue (2020-2031) & (US$ Million)
Figure 61. South Korea Hemostatic Forceps Revenue (2020-2031) & (US$ Million)
Figure 62. China Taiwan Hemostatic Forceps Revenue (2020-2031) & (US$ Million)
Figure 63. India Hemostatic Forceps Revenue (2020-2031) & (US$ Million)
Figure 64. Central and South America Hemostatic Forceps Sales YoY (2020-2031) & (K Units)
Figure 65. Central and South America Hemostatic Forceps Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Central and South America Top 5 Manufacturers Hemostatic Forceps Sales Revenue (US$ Million) in 2024
Figure 67. Central and South America Hemostatic Forceps Sales Volume (K Units) by Type (2021-2031)
Figure 68. Central and South America Hemostatic Forceps Sales Revenue (US$ Million) by Type (2020-2031)
Figure 69. Central and South America Hemostatic Forceps Sales Volume (K Units) by Application (2020-2031)
Figure 70. Central and South America Hemostatic Forceps Sales Revenue (US$ Million) by Application (2020-2031)
Figure 71. Brazil Hemostatic Forceps Revenue (2020-2025) & (US$ Million)
Figure 72. Argentina Hemostatic Forceps Revenue (2020-2025) & (US$ Million)
Figure 73. Middle East, and Africa Hemostatic Forceps Sales YoY (2020-2031) & (K Units)
Figure 74. Middle East and Africa Hemostatic Forceps Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Middle East and Africa Top 5 Manufacturers Hemostatic Forceps Sales Revenue (US$ Million) in 2024
Figure 76. Middle East and Africa Hemostatic Forceps Sales Volume (K Units) by Type (2021-2031)
Figure 77. South America Hemostatic Forceps Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Middle East and Africa Hemostatic Forceps Sales Volume (K Units) by Application (2020-2031)
Figure 79. Middle East and Africa Hemostatic Forceps Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. GCC Countries Hemostatic Forceps Revenue (2020-2025) & (US$ Million)
Figure 81. Turkey Hemostatic Forceps Revenue (2020-2025) & (US$ Million)
Figure 82. Egypt Hemostatic Forceps Revenue (2020-2025) & (US$ Million)
Figure 83. South Africa Hemostatic Forceps Revenue (2020-2025) & (US$ Million)
Figure 84. Hemostatic Forceps Industry Chain Mapping
Figure 85. Regional Hemostatic Forceps Manufacturing Base Distribution (%)
Figure 86. Global Hemostatic Forceps Production Market Share by Region (2020-2031)
Figure 87. Hemostatic Forceps Production Process
Figure 88. Regional Hemostatic Forceps Production Cost Structure
Figure 89. Channels of Distribution (Direct Vs Distribution)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Hemostatic Forceps in 2025?
The global market size of Hemostatic Forceps in 2025 was 67.8 Million USD.
Which region is expected to have the highest market share?
Which companies rank high in the global Hemostatic Forceps market?
What was the global market size of Hemostatic Forceps in 2031?
What is the annual compound growth rate of the global Hemostatic Forceps market size from 2025 to 2031?
Related Reports
Global Hemostatic Forceps Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostatic Forceps market size was US$ 67.75 million in 2025 and is forecast to reach a readjusted size of US$ 90.6 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 115
USD 4250.00
(Single User License)
Global Hemostatic Forceps Market Research Report 2026
The global Hemostatic Forceps market was valued at US$ 67.75 million in 2025 and is anticipated to reach US$ 90.6 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 138
USD 2900.00
(Single User License)
Hemostatic Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostatic Forceps was estimated to be worth US$ 67.75 million in 2025 and is projected to reach US$ 90.6 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 163
USD 3950.00
(Single User License)
Global Hemostatic Forceps Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemostatic Forceps was estimated to be worth US$ 65.2 million and is forecast to reach approximately US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 181
USD 5900.00
(Single User License)
Global Hemostatic Forceps Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemostatic Forceps market size was US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 111
USD 4250.00
(Single User License)
Hemostatic Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemostatic Forceps was estimated to be worth US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 159
USD 3950.00
(Single User License)
Global Hemostatic Forceps Market Research Report 2025
The global market for Hemostatic Forceps was valued at US$ 65.2 million in the year 2024 and is projected to reach a revised size of US$ 87.2 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-01-16
Pages: 117
USD 2900.00
(Single User License)
Global Hemostatic Forceps Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published Date: 2024-04-17
Pages: 207
USD 5600.00
(Single User License)
Global Hemostatic Forceps Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published Date: 2024-04-16
Pages: 186
USD 5900.00
(Single User License)
Global Hemostatic Forceps Market Insights, Forecast to 2030
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published Date: 2024-04-07
Pages: 129
USD 4900.00
(Single User License)
Global Hemostatic Forceps Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostatic Forceps market size was US$ 67.75 million in 2025 and is forecast to reach a readjusted size of US$ 90.6 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 115
USD 4250.00 (Single User License)Global Hemostatic Forceps Market Research Report 2026
The global Hemostatic Forceps market was valued at US$ 67.75 million in 2025 and is anticipated to reach US$ 90.6 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 138
USD 2900.00 (Single User License)Hemostatic Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostatic Forceps was estimated to be worth US$ 67.75 million in 2025 and is projected to reach US$ 90.6 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 163
USD 3950.00 (Single User License)Global Hemostatic Forceps Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemostatic Forceps was estimated to be worth US$ 65.2 million and is forecast to reach approximately US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 181
USD 5900.00 (Single User License)Global Hemostatic Forceps Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemostatic Forceps market size was US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 111
USD 4250.00 (Single User License)Hemostatic Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemostatic Forceps was estimated to be worth US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 159
USD 3950.00 (Single User License)Global Hemostatic Forceps Market Research Report 2025
The global market for Hemostatic Forceps was valued at US$ 65.2 million in the year 2024 and is projected to reach a revised size of US$ 87.2 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-01-16
Pages: 117
USD 2900.00 (Single User License)Global Hemostatic Forceps Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published: 2024-04-17
Pages: 207
USD 5600.00 (Single User License)Global Hemostatic Forceps Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published: 2024-04-16
Pages: 186
USD 5900.00 (Single User License)Global Hemostatic Forceps Market Insights, Forecast to 2030
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published: 2024-04-07
Pages: 129
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now